Body Odor Control Manufacturing: Deodorant Actives, Formats and Claims

Short answer: underarm odor is produced by bacteria metabolizing what the skin secretes, not by sweat itself, so a deodorant has to interrupt that process or bind what it produces. The pH of the formula decides which actives are available to you, and it is also the reason the category's most common complaint, irritation, keeps coming back.

Deodorant looks like the simplest product in the body care aisle and behaves like one of the harder ones. It is applied to skin that is warm, occluded, shaved and repeatedly washed; it contains either no water or a high water content depending on format; and it carries a claim about duration that has to be substantiated rather than asserted. Most consumer complaints trace back to one decision made early — the pH the formula is built around — and most development time goes into what that decision controls: which actives are usable, and how the product feels.

This guide covers where the odor comes from, the design routes available, the active families and what each does to a formula, and the format-level consequences that turn one concept into two manufacturing projects.

Where the odor actually comes from

Fresh sweat from the underarm is close to odorless. The smell appears when skin bacteria metabolize compounds in the secretions, turning material with little smell into volatile fatty acids and sulfur-containing molecules. That single sentence reorganizes the product brief: a deodorant is not competing with sweat, it is competing with a metabolic process that happens after sweat has arrived. Three design routes follow:

1. Reduce the substrate. That is what an antiperspirant does, by reducing sweat flow — effective, and regulated as a drug rather than a cosmetic.
2. Change the conditions the bacteria prefer. The skin's natural acid mantle sits in a mildly acidic range, and formulas that reinforce that environment make life harder for the odor-forming species.
3. Interfere with the products formed — bind or neutralize the volatile molecules after they appear, then manage the scent of the finished product on top of that. A fourth possibility, adding an antimicrobial agent, exists, but the boundary between "supports odor control" and "biocide on skin" is regulatory rather than commercial.

The two routes, and why they are not interchangeable

Antiperspirant and deodorant get discussed as if they were grades of the same product, and they are not. A sweat-reduction claim places the product in a drug framework in the US with its own permitted actives and labelling, which puts it out of scope for anything positioned as a cosmetic deodorant. Everything else above — pH management, odor binding, antimicrobial care, scent — sits inside cosmetic positioning, and that is a real constraint rather than a technicality: it decides the actives available, the claims printable, and in several markets the route to market.

The active families and what they do to the formula

Two rows account for most of the category's complaints. The bicarbonate row is the classic: an alkaline bulk is effective against odor-forming bacteria and simultaneously outside the range underarm skin tolerates, which is why magnesium and acid builds grew as the "sensitive" answer. The tannin row is newer, and it pairs an attractive ingredient story with an awkward manufacturing profile — plant polyphenols brown, react to pH and trace metals, and vary between lots.

The pH decision runs the whole formula

Before any active is chosen, the formula's pH determines what is possible. Three consequences follow in sequence.

• Which actives are usable. Bicarbonate needs an alkaline system; acid actives need an acidic one. They cannot coexist, and a brief listing both contains an unresolved conflict.
• Which preservative system is available. Water-containing formats need protection, and the effective preservative set changes with pH. An acid-based deodorant and an alkaline one will not use the same system.
• Which packaging is compatible. A low-pH roll-on and a low-pH stick do not stress the same component, and liner and closure compatibility has to be checked at the pH the product actually sits at.

The most useful thing a brand can bring to that conversation is an honest answer to what the product claims, because the claim and the pH are one decision seen from two directions: acid systems support a gentleness story, magnesium systems a sensitive-skin story, and a bicarbonate system the strongest "natural works" narrative alongside the highest irritation risk in the category.

One concept, two manufacturing systems

The same consumer product becomes two projects depending on the format, and the differences are manufacturing rather than aesthetic.

• Sticks are gelled systems, frequently anhydrous, formed in a mould and pushed into a swivel package. They need fill temperature control and a defined cooling profile to avoid cracking or a sunken centre, and the structure has to survive a warm warehouse; anhydrous delivery removes the water-activity problem and moves the risk to heat stability and syneresis.
• Creams and balms are emulsions or anhydrous pastes filled into jars or tubes. An emulsion brings back the preservative question and adds separation risk; a paste brings back texture and temperature sensitivity.
• Roll-ons and sprays add variables of their own: a roll-on is usually a liquid emulsion, the format most sensitive to viscosity drift and to the ball-and-seat assembly, while a spray is the hardest to keep uniform because the delivery system rather than the formula decides how much active lands on skin.

The consequence for planning is the MOQ tier, which in our range is set by the manufacturing system rather than the product name, starting from 1,000 pcs per SKU: emulsions from 1,000, surfactant systems from 2,000, stick formats from 3,000, and powders and sheet masks from 5,000. A jar cream and a twist stick with the same formula and the same graphics can therefore land in two different tiers, and the tier on the quotation should be read as a statement about the line rather than the concept. Our deodorant cream programme and the stick formats sit on different lines for exactly this reason, and foot-specific formats add a third set of constraints.

Claims: where odor control copy gets into trouble

• Duration claims need a protocol. "All day" and "24 hours" are performance claims that need evidence produced under a defined method; without it, the claim is the problem, however well the formula performs.
• Sweat reduction is a different category. Any statement implying less perspiration takes the product out of cosmetic positioning in the US, and the same words can read differently in other markets.
• Antibacterial language drifts toward drug claims. Describing what a formula does to the skin's bacterial population is not the same as claiming a health outcome, and the line between them is worth agreeing with a regulatory reviewer before artwork is written.
• "Aluminum-free" is accurate and easy to over-read. It means no antiperspirant claim; it does not mean the product reduces perspiration, and copy implying otherwise recreates the drug claim through the back door.

Development traps that recur

1. Choosing actives before choosing a pH. This is the root cause of most reformulation cycles in the category.
2. Testing odor control on noses in the room rather than under a protocol. A defined application schedule, a blind assessment and a scoring scale turn a perception into a number.
3. Treating fragrance load as the control mechanism. Using scent to cover an odor still forming signals a formula problem rather than solving one.

4. Skipping the skin-tolerance question until complaints arrive. The irritation history of this category is public enough that a first build should assume sensitivity rather than test for it after launch.

5. Designing the pack after the fill. In a swivel stick, fill temperature, cooling and pack tolerances are one decision, and separating them produces a line that cannot hold its weight specification.

A first deodorant project is most successful as one format, one active family and one pH, launched at the tier that format sits in. Extending later is a smaller project than reconciling two systems specified at once, and it keeps the sensory and barrier questions testable on one product.

FAQ

Q: Why does a baking soda deodorant cause a rash when it controls odor well? A: Because both effects come from the same property: bicarbonate raises the product's pH into an alkaline range, which is unfriendly to odor-forming bacteria and also well outside the mildly acidic range of underarm skin. Magnesium and acid builds exist to keep the odor-control benefit while moving the pH back toward what skin tolerates.

Q: Can one deodorant formula be sold as both a deodorant and an antiperspirant? A: No. An antiperspirant claim is a sweat-reduction claim, which places the product in a drug framework in the US with its own permitted actives and labelling, while a cosmetic deodorant claims odor control only. The formula and the claims have to match the route, and an "aluminum-free" statement does not convert one into the other.

Q: Does a deodorant stick and a deodorant cream have the same MOQ? A: Not necessarily, because the floor is set by the manufacturing system rather than the product name. In our range it starts from 1,000 pcs per SKU: emulsions from 1,000, surfactant systems from 2,000, stick formats from 3,000, and powders and sheet masks from 5,000. A jar cream and a twist stick of the same concept can therefore fall into different tiers.

Q: How is odor control actually tested before launch? A: With a defined protocol rather than an informal sniff: an agreed application schedule, a blind assessment of treated and untreated sites, and a scoring scale, usually run alongside the stability work. That is what turns a perceived difference into evidence, and duration or hour-based claims need evidence of that kind before they can be printed.